晚期实体瘤是指已经发生局部扩散或远处转移的实体恶性肿瘤（如肺癌、乳腺癌、胃癌等），通常处于疾病终末期，治疗目标以控制病情进展、延长生存期、缓解症状和提高生活质量为主。在过去的十年中，靶向治疗和免疫治疗已经彻底改变了各种癌症的治疗方法。2026年3月9日，据中国国家药品审评中心（CDE） 官网显示，中山康方生物医药有限公司申报的1类新药注射用AK150临床试验申请获默示许可。拟定适应症为：晚期恶性...
Source Link晚期实体瘤是指已经发生局部扩散或远处转移的实体恶性肿瘤（如肺癌、乳腺癌、胃癌等），通常处于疾病终末期，治疗目标以控制病情进展、延长生存期、缓解症状和提高生活质量为主。在过去的十年中，靶向治疗和免疫治疗已经彻底改变了各种癌症的治疗方法。2026年3月9日，据中国国家药品审评中心（CDE） 官网显示，中山康方生物医药有限公司申报的1类新药注射用AK150临床试验申请获默示许可。拟定适应症为：晚期恶性...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.